at Zacks.com (Jan 12, 2015)
Bayer HealthCare completes the acquisition of Teva's (TEVA +0.1%) U.S.-based animal health business after receiving the necessary regulatory approvals. Teva will receive up to $145M following the achievement of manufacturing and sales targets. The sale is no doubt part of the Israeli company's restructuring.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 9, 2015)
at CNBC.com (Jan 5, 2015)
at Zacks.com (Dec 31, 2014)
at Nasdaq.com (Dec 31, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs